Cronos (CRON) Invested Capital (2021 - 2023)

Cronos' (CRON) quarterly Invested Capital came in at $375000.0 in Q1 2023, down 2.34% quarter-over-quarter from $384000.0 in Q4 2022.

Cronos (CRON) Invested Capital (2021 - 2023) Analysis & Trends

Cronos' Invested Capital history runs 3 years deep, the most recent figure standing at $375000.0 for Q1 2023.

  • On a quarterly basis, Invested Capital changed N/A year-over-year to $375000.0 in Q1 2023; TTM through Dec 2023 was $375000.0, a 50.85% decrease from a year earlier, with the FY2022 full-year figure at $384000.0, down 11.32% from the prior year.
  • Invested Capital fell to $375000.0 in Q1 2023 per CRON's latest filing, from $384000.0 in the prior quarter.
  • Across five years, Invested Capital topped out at $433000.0 in Q4 2021 and bottomed at $375000.0 in Q1 2023.
  • The 3-year median for Invested Capital is $381500.0 (2022), against an average of $392750.0.
  • Biggest YoY gain for Invested Capital was 11.32% in 2022; the steepest drop was 11.32% in 2022.
  • Year by year, Invested Capital stood at $433000.0 in 2021, then dropped by 11.32% to $384000.0 in 2022, then slipped by 2.34% to $375000.0 in 2023.
  • Per Business Quant, the three latest CRON Invested Capital figures stand at $375000.0 (Q1 2023), $384000.0 (Q4 2022), and $379000.0 (Q3 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.11 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 2.61 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 31.13 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 7.15 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.93 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 73.00 Mn
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 375,000.00
Dec 31, 2022 384,000.00
Sep 30, 2022 379,000.00
Dec 31, 2021 433,000.00